What You Ought to Know:
– RadNet, Inc., a supplier of diagnostic imaging companies and digital well being options, introduced the acquisition of CIMAR UK, a supplier of cloud-native healthcare picture administration options. Monetary particulars of the acquisition weren’t disclosed.
– CIMAR will likely be built-in into DeepHealth, RadNet’s wholly owned subsidiary and a world chief in AI-powered well being informatics, to considerably advance linked imaging-based care.
CIMAR’s UK Market Dominance and Interoperability
CIMAR’s major power is its in depth picture administration infrastructure, which gives essential knowledge connectivity and interoperability.
Within the UK, CIMAR has established a major footprint, enabling vendor-neutral options, together with medical AI, throughout:
- Greater than 50% of Nationwide Well being Service (NHS) Trusts.
- 80% of UK non-public hospital teams.
The acquisition combines CIMAR’s cloud-native infrastructure and companies with DeepHealth’s main end-to-end informatics and inhabitants well being functions, akin to AI-based reporting and workflow instruments. This union is predicted to create a richer answer for advancing coordinated and accessible care.
AI-Powered Screening Success and Future Enlargement
The complementary applied sciences have already demonstrated vital success by an current partnership that underpins the NHS England’s Lung Most cancers Screening Program. CIMAR gives the digital infrastructure connecting DeepHealth’s AI lung answer throughout greater than 90% of this system’s screening websites.
This linked, AI-powered program has achieved outstanding outcomes:
- Greater than three-quarters (76%) of lung cancers detected are actually caught at earlier, extra treatable levels.
- Traditionally, solely 29% of lung cancers had been caught at these levels.
With this acquisition, DeepHealth goals to duplicate and scale these digitally enabled care fashions throughout the UK and Europe for different screening and diagnostic applications.
